- Filed
- May 6, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Short Term Investments | Q1 2025 · Mar 31, 2025 | $64.1M |
| Short Term Investments | Q1 2025 · Dec 31, 2024 | $19.94M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $73.76M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $37M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $18.95M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $21.74M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $34.25M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $99.07M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $143.21M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $62.14M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $150.7M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $70.09M |
| Shares Diluted restated | Q1 2025 · Mar 31, 2024 | 6.25M sh |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | −$22.75M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $59.8M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $92.08M |
| Eps Diluted restated | Q1 2025 · Mar 31, 2024 | −$5.58 |
| Eps Basic restated | Q1 2025 · Mar 31, 2024 | −$5.58 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $6.67M |
| Rd Expense | Q1 2025 · Mar 31, 2024 | $16.37M |
| Net Income | Q1 2025 · Mar 31, 2024 | −$34.86M |
| Operating Income | Q1 2025 · Mar 31, 2024 | −$22.05M |
| Revenue | Q1 2025 · Mar 31, 2024 | $694K |